Has Ryan Pham, DO received payments from drug or device companies?

Yes. Drug and device makers reported $73,276 in general payments to Ryan Pham, DO across 1,432 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Ryan Pham, DO did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Ryan Pham, DO come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Ryan Pham, DO

Dermatology · Burleson, TXNPI 1407173230

Payments from drug & device makers

$73,276in general payments, 2019–2025

Across 1,432 payments — averaging $51.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Lilly USA, LLC$40K
AbbVie$5K
Amgen$3K
E.r. Squibb & Sons, L.L.C.$2K
Sanofi$2K
Promius Pharma LLC$2K
plus $19K from 46 others

What the payments were for

Consulting fees$1,8002%
Speaking & faculty fees$36,79950%
Travel & lodging$2,4343%
Food & beverage$31,78143%
Education$4611%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Lilly USA, LLC	124	$39,521
AbbVie(2 entities)	166	$4,612
Amgen	108	$3,054
E.r. Squibb & Sons, L.L.C.	22	$2,345
Sanofi	78	$2,326
Promius Pharma LLC	3	$2,121
Galderma Laboratories, L.p.	65	$2,018
UCB, Inc.	102	$1,905
Mayne Pharma Commercial LLC	140	$1,836
Johnson & Johnson	91	$1,711
LEO Pharma Inc.	65	$1,663
Novartis	61	$1,434
Regeneron Healthcare Solutions, Inc.	56	$1,410
Bristol Myers Squibb	27	$796
Ortho Dermatologics, A Division Of Bausch Health US, LLC	48	$774
Biofrontera Inc.	41	$718
Dermavant Sciences, Inc.	17	$668
Pfizer	21	$532
Sun Pharmaceutical Industries Inc.	25	$512
Arcutis Biotherapeutics, Inc.	32	$483
Encore Dermatology Inc.	31	$370
Almirall LLC	23	$306
Journey Medical Corporation	7	$291
Incyte Corporation	12	$230
Sebela Pharmaceuticals Inc.	11	$189
Organon	3	$169
Alcon	1	$148
Paratek Pharmaceuticals, Inc.	6	$128
Boehringer Ingelheim	5	$107
Janssen Scientific Affairs, LLC	1	$101
EPI Health, LLC	1	$99
Medimetriks Pharmaceuticals, Inc.	4	$71
Glenmark Therapeutics Inc.	6	$71
Sandoz	4	$67
Botanix SB Inc	3	$57
Prugen, Inc. Pharmaceuticals	1	$56
Genentech USA, Inc.	2	$50
VYNE Pharmaceuticals Inc.	3	$48
Nabriva Therapeutics, PLC	2	$34
Sensus Healthcare, Inc.	2	$28
Smith+Nephew	1	$23
Verrica Pharmaceuticals Inc.	1	$22
Dermira, Inc.	1	$22
Novum Pharma, LLC	1	$20
Helsinn Therapeutics (U.S.), Inc.	1	$19
Mylan Pharmaceuticals Inc.	1	$19
Aclaris Therapeutics, Inc.	1	$17
Tempus AI, Inc	1	$16
LNHC, Inc	1	$16
Blueprint Medicines Corporation	1	$14
Lumenis, Inc	1	$14
Merck	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

EBGLYSS$32,351
TRIANEX 0.05%$2,121
Promiseb Complete$2,121
Sernivo$2,121
Otezla$1,641
DUPIXENT$825
VTAMA$688
Skyrizi$566
Rinvoq$463
NEMLUVIO$426
Tremfya$354
Precision 1$148
EPSOLAY$131
COSENTYX$125
AMELUZ$125
BF-RhodoLED$125
XEPI$125
Bimzelx$122
TALTZ$119
AKLIEF$118

How this compares

$73,276 in reported general payments places this provider in the 90th percentile of 1,098 dermatology providers in Texas.

See all dermatology providers in Texas →

Medicare billing

Part B allowed, 2024

$374,601

Medicare patients

694

Services billed

12,471

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Skyrizi PenRisankizumab-Rzaa	13	$285,268
Dupixent PenDupilumab	24	$92,012
Clobetasol Propionate	260	$9,067
Doxycycline Hyclate	104	$2,530
Ciclopirox	25	$2,405
Ketoconazole	143	$2,219
Calcipotriene	11	$2,048
Mupirocin	137	$1,551
Betamethasone Dipropionate	32	$1,471
Triamcinolone Acetonide	123	$873
Doxycycline Monohydrate	14	$708
Imiquimod	11	$392
Fluconazole	26	$292
Lidocaine	12	$290
Clindamycin Phosphate	11	$252

Paid to pharmacies, not to this prescriber.

Other dermatology in Burleson

Stephen TyringWebster$14.1M
Edward LainAustin$12M
Mark LeeSan Antonio$10.9M
John BrowningSan Antonio$10.7M
Craig TellerBellaire$7.7M
Patricia LeeWebster$7.2M
Jennifer CatherDallas$4.9M
Michael MigdenHouston$3.7M
Martin MenterDallas$3.7M
Janet DuboisAustin$3.5M

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →